WE Red Bridge appointed as comms agency of record of Cytel in China

Beijing, China – Integrated communications agency WE Red Bridge has been appointed by Cytel, the provider of statistical software and advanced analytics for clinical trial design and execution, as its communications agency of record in China. The appointment, which will be led by Martin Xu, WE Red Bridge’s director of technology, comes at a time of significant growth for the agency.

As part of the remit, WE Red Bridge will be supporting Cytel’s launch in China, and handling stakeholder engagement and media relations activities. The agency will also be bolstering the company’s position as a statistical innovation leader in the biopharma clinical research sector through thought leadership and experiential programs. In addition, WE Red Bridge will be supporting Cytel’s initiatives in complex and adaptive designs, as well as expanding the industry-leading East and Solara platforms for clinical trial strategy and design.

Jing Ping Yeo, Cytel’s vice president and head of APAC, noted that Cytel’s mission is to help biotech and pharmaceutical leaders unlock the power of data to solve their toughest problems and make evidence-driven decisions with confidence.

“WE Red Bridge’s emphasis on data-driven intelligence and extensive media relations experience makes the agency an ideal partner for introducing Cytel to the Chinese market,” said Yeo.

Meanwhile, Tony Zhang, general manager of Beijing and head of corporate at WE Red Bridge, said, “The intersection of health and technology is at the centre of the global pandemic response, and we have seen how quickly the ecosystem must adapt to change. Martin and his team bring the expertise, strategy and nuance necessary for today’s complex healthtech needs. We look forward to helping Cytel accelerate its growth in China.”

Earlier this year, WE Red Bridge has also been appointed by automotive brand McLaren in China as its communications agency of record. This appointment will see WE Red Bridge supporting the automaker’s growth in China by increasing brand equity and exposure in the country.